Nucor earnings beat by $0.08, revenue fell short of estimates
Investing.com -- Loomis (LON:0JYZ) AB, through its subsidiary Loomis International Corporate AG, has agreed to acquire 100 percent of Kipfer-Logistik GmbH, a Swiss logistics company specializing in temperature-controlled transport and storage for pharmaceutical and healthcare sectors.
Kipfer-Logistik generated approximately CHF 9 million (SEK 108 million) in revenue during 2024 and employs 28 people. The acquisition is expected to be completed on September 1, 2025, subject to certain conditions.
The acquired business will be integrated into the International business line within Loomis’s Europe and Latin America Segment. Loomis has been offering transportation of pharmaceutical products in temperature-controlled environments in Switzerland since 2024 under its Loomis Pharma brand.
"This acquisition accelerates the growth of Loomis Pharma by integrating a well-established Swiss logistics company specializing in high-security and temperature-controlled road freight transport. Together, we will provide our customers with an even more comprehensive range of services, thereby strengthening our market position," said Aritz Larrea, President and CEO of Loomis.
The acquisition is expected to boost the Group’s operating profit (EBITA1) and earnings per share for 2025.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.